Legend Biotech Corp is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LEGN is expected to report earnings to fall 49.55% to -5 cents per share on March 18
Q4'25
Est.
$-0.06
Q3'25
Missed
by $0.07
Q2'25
Beat
by $0.15
Q1'25
Missed
by $0.06
Q4'24
Beat
by $0.09
The last earnings report on November 12 showed earnings per share of -10 cents, missing the estimate of -4 cents. With 2.44M shares outstanding, the current market capitalization sits at 5.21B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LEGN showed earnings on November 12, 2025. You can read more about the earnings report here.